Meanwhile, other antigen targets for B-cell lymphomas have been explored in pre-clinical development, including B-cell activating factor receptor (BAFF-R), CD79a, CD37 and Ig-kappa, as well as others. Here, TNFRSF13C is linked to B-cell non-Hodgkin lymphoma.